ReviewCell biology international2026
Mitoxyperiosis: A Novel Mitochondria-Driven Cell Death Mechanism in Immunometabolic Stress.
Review in Cell biology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitoxyperiosis: A Novel Mitochondria-Driven Cell Death Mechanism in Immunometabolic Stress.Cell biology international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Wang et al. recently proposed mitoxyperiosis as a previously uncharacterized, mitochondria-dependent form of lytic cell death triggered by immunometabolic stress. Unlike apoptosis, pyroptosis, necroptosis, or ferroptosis, mitoxyperiosis is driven by sustained oxidative stress and prolonged mitochondria-plasma membrane contact, culminating in localized oxidative membrane damage and non-caspase-dependent rupture, termed mitoxyperilysis. Central to this mechanism is the activation of mechanistic target of rapamycin complex 2 (mTORC2), which suppresses actin cytoskeletal remodeling and inhibits lamellipodia formation, thereby retaining mitochondria at the cell periphery. Remarkably, mTORC2 inhibition or the restoration of cytoskeletal dynamics prevents membrane rupture despite persistent oxidative stress. This review synthesizes mechanistic insights and experimental evidence underlying mitoxyperiosis and examines its implications for tumor biology and inflammatory disease. We further discuss how this pathway may expand current understanding of spatial control in regulated cell death and may provide therapeutic opportunities targeting mitochondrial positioning and mTORC2 signaling in immunometabolic disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.